脓毒症患者右心室功能与短期死亡风险的关联
该回顾性队列研究纳入江苏大学附属人民医院重症医学科2020年1月至2023年12月收治的196例成人脓毒症患者,比较存活组与死亡组的临床及超声心动图特征。196例中157例存活、39例死亡;死亡组尿量更少、接受CRRT比例更高、APACHE II评分更高、乳酸更高、血管活性药物剂量更大、需要机械通气比例更高,TAPSE、右心室面积变化分数及LVEF更低。196例中136例(69.4%)出现心室功能障碍,右心室功能障碍96例(49.0%);单纯右心室功能障碍者30天死亡率最高(36.0%),无心室功能障碍者最低(13.8%)。多因素Logistic回归显示右心室功能障碍(OR=2.34)是30天死亡的独立危险因素。
要点
- 脓毒症患者右心室功能障碍发生率49.0%(96/196),是30天死亡的独立危险因素(OR=2.34,95%CI 1.21-3.78)。
- 单纯右心室功能障碍者30天死亡率36.0%(18/50),高于双心室功能障碍30.4%(14/46)、单纯左心室功能障碍22.5%(9/40)及无心室功能障碍13.8%(8/60)。
- 有右心室功能障碍者30天死亡率40.6%(39/96),高于无右心室功能障碍者21.0%(21/100)。
- 有右心室功能障碍者乳酸更高(7.8±3.4 mmol/L vs 4.2±2.3 mmol/L)、APACHE II评分更高(13(1,41)vs 7(1,34))。
- 死亡组TAPSE更低(16.0±3.6 mm vs 19.3±4.4 mm)、右心室面积变化分数更低((30.23±8.14)% vs(33.69±7.81)%)。
适用人群与场景
- 江苏大学附属人民医院重症医学科2020年1月至2023年12月收治的196例成人脓毒症患者。
- 研究比较30天存活者(157例)与死亡者(39例)。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量196例成人脓毒症患者;单中心(江苏大学附属人民医院重症医学科);时间2020年1月至2023年12月。
- 30天结局:存活157例、死亡39例;死亡组尿量更少、接受CRRT比例更高、APACHE II评分更高、乳酸更高、血管活性药物剂量更大、需要机械通气比例更高。
- 超声心动图:死亡组TAPSE(16.0±3.6 mm vs 19.3±4.4 mm)、右心室面积变化分数((30.23±8.14)% vs(33.69±7.81)%)、LVEF(0.575±0.129 vs 0.637±0.069)均低于存活组,右心室收缩末期面积(15.75±4.45 cm² vs 14.27±3.39 cm²)及E/E'(9.18±4.43 vs 7.74±3.12)均高于存活组,均P<0.05。
- 心室功能障碍分布:136例(69.4%)出现心室功能障碍,其中单纯右心室功能障碍50例(25.5%)、单纯左心室收缩功能障碍33例(16.8%)、单纯左心室舒张功能障碍7例(3.6%)、左心室收缩功能障碍合并右心室功能障碍25例(12.8%)、右心室功能障碍合并左心室舒张功能障碍1例(0.5%)、左心室收缩功能障碍合并左心室舒张功能障碍及右心室功能障碍20例(10.2%)。
- 30天死亡率:单纯右心室功能障碍36.0%(18/50)最高,双心室功能障碍30.4%(14/46)次之,单纯左心室功能障碍22.5%(9/40),无心室功能障碍13.8%(8/60)最低,差异有统计学意义(P<0.05)。
- 右心室功能障碍者96例(49.0%),与无右心室功能障碍者相比:急性肾衰竭发生率63.5%(61/96)vs 48.0%(48/100)、APACHE II评分13(1,41)vs 7(1,34)、乳酸7.8±3.4 mmol/L vs 4.2±2.3 mmol/L、液体复苏量2 032±225 mL vs 1 123±115 mL、血管活性药物剂量1.1(0.2,2.1)μg×kg⁻¹×min⁻¹ vs 0.7(0.2,2.0)μg×kg⁻¹×min⁻¹、需要机械通气比例18.8%(18/96)vs 15.0%(15/100)、30天死亡率40.6%(39/96)vs 21.0%(21/100),均P<0.05。
- 多因素Logistic回归显示30天死亡的独立危险因素:CRRT(OR=2.43,95%CI 0.25-0.64)、较高APACHE II评分(OR=1.35,95%CI 1.21-1.65)、较高乳酸(OR=13.44,95%CI 6.15-25.35)、较高血管活性药物剂量(OR=65.45,95%CI 19.88-195.83)、机械通气(OR=92.45,95%CI 34.67-369.45)、右心室功能障碍(OR=2.34,95%CI 1.21-3.78)、左心室舒张功能障碍(OR=2.35,95%CI 1.09-5.18),均P<0.05。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 脓毒症早期应关注右心室功能,右心室功能障碍与30天死亡风险升高相关(OR=2.34,95%CI 1.21-3.78)。
- 合并右心室功能障碍的脓毒症患者急性肾衰竭发生率、乳酸水平、液体复苏量、血管活性药物剂量及30天死亡率均更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the right ventricular function in patients with sepsis and to analyze the association between right ventricular dysfunction and 30-day mortality.
METHODS: A retrospective cohort study was conducted. The clinical data from 196 adult patients with sepsis admitted to the department of critical care medicine of the Affiliated People's Hospital of Jiangsu University from January 2020 to December 2023 were collected, including age, gender, mean arterial pressure (MAP), oxygenation index (PaO2/FiO2), heart rate (HR), urine output, continuous renal replacement therapy (CRRT), presence of acute renal failure, Acute Physiology And Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure Assessment (SOFA) score, Elixhauser comorbidity index (ECI) score, blood lactic acid (Lac), fluid resuscitation volume, vasoactive drug dose, mechanical ventilation status, echocardiographic parameters within 24 hours after admission, and 30-day outcomes. Demographic, clinical, and echocardiographic features were compared between survivors and non-survivors. The prevalence and death risk of ventricular dysfunction subtypes in patients with sepsis were analyzed. Multivariate Logistic regression analysis was used to identify independent risk factors for short-term death risk.
RESULTS: Among 196 patients with sepsis, 157 survived for 30 days and 39 died. Compared with the survival group, the patients in the non-survival group had less urine output, a higher proportion of patients receiving CRRT, higher APACHE II score, higher Lac, higher doses of vasoactive drugs, and a higher proportion of requiring mechanical ventilation. Echocardiography showed that the patients in the non-survival group had lower tricuspid annular peak systolic excursion (TAPSE), right ventricular fractional area change, and left ventricular ejection fraction (LVEF) as compared with those in the survival group [TAPSE (mm): 16.0±3.6 vs. 19.3±4.4, right ventricular fractional area change: (30.23±8.14)% vs. (33.69±7.81)%, LVEF: 0.575±0.129 vs. 0.637±0.069, all P<0.05], and higher right ventricular end-systolic area and ratio of left ventricular early diastolic mitral flow velocity to mitral annular motion velocity [E/E'; right ventricular end-systolic area (cm2): 15.75±4.45 vs. 14.27±3.39, left ventricular E/E' ratio: 9.18±4.43 vs. 7.74±3.12, both P<0.05]. Among 196 patients with sepsis, 136 patients (69.4%) developed ventricular dysfunction, including isolated right ventricular dysfunction in 50 (25.5%), isolated left ventricular systolic dysfunction in 33 (16.8%), isolated left ventricular diastolic dysfunction in 7 (3.6%), combined left ventricular systolic dysfunction and right ventricular dysfunction in 25 (12.8%), combined right ventricular dysfunction and left ventricular diastolic dysfunction in 1 (0.5%), and combined left ventricular systolic dysfunction, left ventricular diastolic dysfunction, and right ventricular dysfunction in 20 (10.2%). The 30-day mortality was highest in patients with isolated right ventricular dysfunction [36.0% (18/50)], followed by those with biventricular dysfunction [30.4% (14/46)] and isolated left ventricular dysfunction [22.5% (9/40)], and lowest in patients without ventricular dysfunction [13.8% (8/60)], with statistically significant difference (P<0.05). Among 196 patients with sepsis, right ventricular dysfunction occurred in nearly half of all patients [96 cases (49.0%)]. Compared with those without right ventricular dysfunction, the patients with right ventricular dysfunction had higher incidence of acute renal failure, higher APACHE II score, higher Lac, higher fluid resuscitation volume, higher vasoactive drug dose, higher ratio of requiring mechanical ventilation, and higher 30-day mortality [incidence of acute renal failure: 63.5% (61/96) vs. 48.0% (48/100), APACHE II score: 13 (1, 41) vs. 7 (1, 34), Lac (mmol/L): 7.8±3.4 vs. 4.2±2.3, fluid resuscitation volume (mL): 2 032±225 vs. 1 123±115, vasoactive drug dose (μg×kg-1×min-1): 1.1 (0.2, 2.1) vs. 0.7 (0.2, 2.0), ratio of requiring mechanical ventilation: 18.8% (18/96) vs. 15.0% (15/100), 30-day mortality: 40.6% (39/96) vs. 21.0% (21/100), all P<0.05]. Multivariate Logistic regression analysis identified CRRT [odds ratio (OR)=2.43, 95% confidence interval (95%CI) was 0.25-0.64], higher APACHE II score (OR=1.35, 95%CI was 1.21-1.65), higher Lac (OR=13.44, 95%CI was 6.15-25.35), higher vasoactive drug dose (OR=65.45, 95%CI was 19.88-195.83), mechanical ventilation (OR=92.45, 95%CI was 34.67-369.45), right ventricular dysfunction (OR=2.34, 95%CI was 1.21-3.78), and left ventricular diastolic dysfunction (OR=2.35, 95%CI was 1.09-5.18) as independent risk factors of 30-day death in patients with sepsis (all P<0.05).
CONCLUSIONS: Right ventricular dysfunction is common in patients with early sepsis and serves as an independent risk factor for 30-day death.
参考来源
- Xiong F, Yang H, Yan J, et al. [Association between right ventricular function and short-term death risk in patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 41833348. doi:10.3760/cma.j.cn121430-20240426-00217
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。